<DOC>
	<DOC>NCT02636244</DOC>
	<brief_summary>The purpose of this study is to evaluate the efficacy and safety of SHAPE Gel applied topically to adult patients with alopecia areata of the scalp.</brief_summary>
	<brief_title>Safety and Efficacy Study of SHAPE Gel in Alopecia Areata</brief_title>
	<detailed_description />
	<mesh_term>Alopecia</mesh_term>
	<mesh_term>Alopecia Areata</mesh_term>
	<mesh_term>Histone Deacetylase Inhibitors</mesh_term>
	<criteria>Diagnosis of scalp alopecia areata and scalp hair loss due to alopecia areata for a minimum of six months and a maximum of two years. Patients taking thyroid medication or hormonal therapy must be on a stable dose for 6 months and maintain such throughout the study. Willingness to maintain same hair style, including shampoo and hair dye, throughout the study period. Willingness to have a small micro dot tattoo placed to allow for photographic analysis of treatment and application of study medication. History of systemic or cutaneous malignancy and/or lymphoproliferative disease, other than patients with: up to 3 basal cell carcinoma; up to three well differentiated cutaneous squamous cell carcinoma; and/or cervical intraepithelial neoplasm (CIN), treated successfully with no evidence of disease, and treated for greater than 6 months prior to study entry. Current actinic keratosis on the scalp and/or face Nevi or cutaneous lesions thought suspicious for malignancy. History of or current gastrointestinal, pulmonary, cardiovascular, genitourinary or hematological disease, CNS disorders, infectious disease or coagulation disorders that would preclude participation in and completion of study assessments. Positive for hepatitis B surface antigen, HIV or hepatitis C. Coexistent androgenetic alopecia: in males: NorwoodHamilton stage IV, V or VI; in females: Ludwig stage II or III. Unwillingness to discontinue use of nonbreathable wigs, weaves or shaving of scalp throughout course of study.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>